Connect with us

Hi, what are you looking for?

Jewish Business News


The Trouble With Disney’s Great Man Theory

walt disney

Disney has been a winning stock since Bob Iger took over from Michael Eisner in 2005, with the stock rising 300%. Under Eisner’s guidance, the company was faltering, with a hostile takeover bid and disgruntled shareholders. Iger made a series of smart acquisitions, including Pixar, Marvel and most recently, LucasFilms. Iger retained the talent at the companies bought by Disney, expanded the brands to include sequels, action figures and other toys, and has restored Disney’s former glory; some would say, expanded it into an entertainment power house, as discussed on Motley Fool.

The best is yet to come for Disney, some would say, with upcoming releases of “Star Wars” films and the opening of a theme park in Shanghai. There is one major problem; What will happen to Disney when Iger leaves? The CEO’s contract has been extended until 2018, but it is possible that he may retire before that. Luckily, Iger retained enough talent in the bloodlines of the companies he bought to keep them strong, but where is the genius that will coordinate the disparate elements? Motley Fool mentions that CFO Jay Rasulo and the parks and resorts chairman Thomas Staggs, might be candidates, but both lack Iger’s media experience, which he gained at ABC.

Disney’s great strength, in the form of Bob Iger, may be its biggest weakness. Warren Buffett said that Coca-Cola’s brand was so strong that even a “ham sandwich” could run the company. Disney is also a strong brand, but it depends on brain and innovation behind the brand, and it is a company with a “great man theory, “; once the master CEO retires, the future will be uncertain.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.